Paper

Abstract B013: KAT6A/B Inhibition Durably Reprograms Neuroblastoma Cell State to Enhance Retinoid Response and GD2-Directed Immunotherapy

Clinical Cancer Research · 2026 · Francesca Alvarez Calderon, Ulrike Gerdemann, Silvi Salhotra et al.